Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
ETON
#2570
Eton Pharmaceutcials, Inc. Common Stock
16.9
9
-0.93%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-0.93%
Monatliche Änderung
+13.04%
6 month change
-2.80%
Jahresänderung
+13.12%
Vorheriger Schlusskurs
17.1
5
Open
16.9
9
Bid
Ask
Low
16.9
9
High
16.9
9
Volumen
47
Märkte
Aktien
Gesundheitswesen
ETON
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
25.84 M
26.82 M
26.82 M
26.82 M
26.82 M
—
Valuation ratios
Enterprise value
134.76 M
342.27 M
330.67 M
356.77 M
545.62 M
1.58 B
Price to earnings ratio
-27.53
-90.22
-71.49
-90.37
-87.73
-339.82
Price to sales ratio
0.02
8.84
7.04
6.49
8.26
30.62
Price to cash flow ratio
-0.06
355.96
61.44
31.08
27.46
475.94
Price to book ratio
0.01
14.12
4.34
4.24
6.03
28.72
Enterprise value to EBITDA ratio
-38.2
-1 000.8
182.09
70.96
90.26
-657.49
Profitability ratios
Return on assets %
0.02
-0.01
0.02
0.03
0.02
0.05
Return on equity %
0.04
-0.03
0.06
0.11
0.08
0.23
Return on invested capital %
14.59
-20.59
3.55
10.92
9.77
3.64
Gross margin %
61.04
55.6
57.06
63
34.97
210.63
Operating margin %
4.93
-14.14
2.72
7.79
6.07
2.44
EBITDA margin %
7.85
24.06
4.84
3.06
8.13
40.09
Net margin %
6.07
-5.63
9.1
13.66
8.58
25.7
Liquidity ratios
Quick ratio
1.41
1.29
1.43
1.16
1.25
5.13
Current ratio
1.51
2.06
1.97
1.77
1.63
7.43
Inventory turnover
2.01
0.6
0.51
0.37
0.72
2.21
Asset turnover
0.31
0.21
0.22
0.2
0.22
0.85
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.12
0.39
0.36
0.27
0.26
1.28
Long term debt to total equity ratio
0.26
1.22
1.23
1.14
1.19
4.78
Per share metrics
Operating cash flow per share
0.02
-0.03
0.08
0.3
0.45
0.79
EBIT per share
0.02
0.02
-0.02
-0.05
-0.05
-0.1
EBITDA per share
0.03
0.11
0.03
0.02
0.07
0.23
Total debt per share
—
—
—
—
—
—
Cash per share
0.76
0.58
0.65
0.94
1.38
3.55
Net current asset value per share
1.12
1.58
1.86
2.55
2.68
8.66
Tangible book value per share
0.38
-0.4
-0.35
-0.33
-0.33
-1.41
Working capital per share
0.38
0.81
0.92
1.11
1.03
3.87
Book value per share
0.6
0.94
0.91
0.89
0.86
3.6
Nachrichten
FDA-Zulassung für DESMODA: Eton Pharmaceuticals zielt auf Markt für Diabetes insipidus
DESMODA oral solution receives FDA approval for diabetes insipidus
Lizenz-Deal für Medikament beflügelt Eton Pharmaceuticals-Aktie
Eton Pharmaceuticals stock rises after licensing ultra-rare disease drug
Eton Pharmaceuticals lizenziert Wirkstoffkandidaten für extrem seltene Krankheit
Eton Pharmaceuticals licenses ultra-rare disease treatment candidate
Implied Volatility Surging for Eton Pharmaceuticals Stock Options
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates
Eton Pharmaceuticals: EPS verfehlt Schätzungen um 0,07 $ - Umsatz besser als erwartet
Eton Pharmaceuticals earnings missed by $0.07, revenue topped estimates
Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday
Eton Stock Has Focused Growth But Valuation Limits Upside: Why I Choose To Hold